SOM Biotech

Biotechnology company specializing in drug discovery

Logo of SOM Biotech

SOM Biotech is a biotechnology company focused on the discovery and development of drugs for the treatment of rare diseases. The company is headquartered in Barcelona, Spain, and utilizes a proprietary drug discovery platform to identify new therapeutic uses for existing drugs, a process known as drug repositioning.

History

SOM Biotech was founded in 2009 by Dr. Raúl Insa, a physician with extensive experience in the pharmaceutical industry. The company was established with the aim of addressing unmet medical needs in the field of rare diseases by leveraging its innovative drug discovery technology.

Technology

SOM Biotech employs a proprietary computational platform that uses advanced algorithms to analyze the molecular structure of existing drugs. This platform allows the company to identify potential new indications for these drugs, accelerating the drug development process and reducing costs. The technology is particularly effective in identifying treatments for rare diseases, where traditional drug development approaches may be less viable due to limited patient populations.

Pipeline

The company's pipeline includes several drug candidates in various stages of development. These candidates target a range of rare diseases, including neurological disorders, oncology, and metabolic disorders. SOM Biotech's approach to drug repositioning has enabled it to rapidly advance its pipeline, with some candidates already in clinical trials.

Collaborations and Partnerships

SOM Biotech has established collaborations with various academic institutions, research organizations, and pharmaceutical companies. These partnerships are aimed at enhancing the company's drug discovery efforts and expanding its reach in the global market. By working with external partners, SOM Biotech is able to access additional resources and expertise, furthering its mission to develop effective treatments for rare diseases.

Awards and Recognition

The company has received several awards and recognitions for its innovative approach to drug discovery and its contributions to the field of rare diseases. These accolades highlight SOM Biotech's commitment to improving patient outcomes and advancing medical research.

Related pages

• Biotechnology
• Drug discovery
• Rare diseases
• Drug repositioning